Home › Tumor sa Utak › Michigan › Ann Arbor
Pag-aaral pangklinika para sa Tumor sa Utak sa Ann Arbor, MI
Isang pag-aaral para sa Tumor sa Utak ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa Ann Arbor. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.
Opisyal na teksto ng pag-aaral (English)
A Study of BMS-986504 Monotherapy and in Combination With Other Agents in Participants With Advanced and/or Metastatic Solid Tumors With Homozygous MTAP Deletion (MountainTAP-5)
Nagre-recruitPhase 2
- Local Institution - 0119, Ann Arbor
A Study to Compare the Administration of Encorafenib + Binimetinib + Nivolumab Versus Ipilimumab + Nivolumab in BRAF-V600 Mutant Melanoma With Brain Metastases
Nagre-recruitPhase 2
- University of Michigan Comprehensive Cancer Center, Ann Arbor
- University of Michigan - Brighton Center for Specialty Care, Brighton · 18 mi ang layo
Molecular and Clinical Risk-Directed Therapy for Infants and Young Children With Newly Diagnosed Medulloblastoma
Nagre-recruitPhase 2
- C.S. MOTT Children's Hospital, University of Michigan, Ann Arbor
A Phase 1/1b Study of IAM1363 in HER2 Cancers
Nagre-recruitPhase 1
- University of Michigan, Ann Arbor
Targeted Pediatric High-Grade Glioma Therapy
Nagre-recruitObservasyonal na pag-aaral
- C.S. Mott Children's Hospital, Ann Arbor
Virus-Based Gene Therapy (AdV-HSV1-TK and AdV-Flt3L) in Combination With Valacyclovir for the Treatment of Pediatric and Young Adult Patients With Resectable, Recurrent Primary Malignant Brain Tumors
Nagre-recruitPhase 1
- University of Michigan Comprehensive Cancer Center, Ann Arbor
Stereotactic Radiosurgery Compared With Hippocampal-Avoidant Whole Brain Radiotherapy (HA-WBRT) Plus Memantine for 5 or More Brain Metastases
Nagre-recruitPhase 3
- University of Michigan Rogel Cancer Center, Ann Arbor
Study of Ribociclib and Everolimus in HGG and DIPG or Ribociclib and Temozolomide in DHG, H3G34-mutant
Nagre-recruitPhase 2
- C.S. Mott Children's Hospital, Ann Arbor
CAR T Cells After Lymphodepletion for the Treatment of IL13Rα2 Positive Recurrent or Refractory Brain Tumors in Children
Nagre-recruitPhase 1
- C.S. Mott Children's Hospital, University of Michigan, Ann Arbor
S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac Toxicity
Nagre-recruitPhase 3
- Saint Joseph Mercy Hospital, Ann Arbor
- University of Michigan Comprehensive Cancer Center, Ann Arbor
- Trinity Health IHA Medical Group Hematology Oncology Ann Arbor Campus, Ypsilanti · 7 mi ang layo
Pag-aaral para sa Tumor sa Utak sa ibang lungsod
- Houston, TX35 pag-aaral
- Boston, MA28 pag-aaral
- New York City, NY25 pag-aaral
- Washington, DC21 pag-aaral
- Los Angeles, CA16 pag-aaral
- Miami, FL15 pag-aaral
- Durham, NC14 pag-aaral
- St. Louis, MO12 pag-aaral
- Rochester, MN12 pag-aaral
- Seattle, WA11 pag-aaral
- Chicago, IL11 pag-aaral
- Columbus, OH11 pag-aaral
Iba pang pag-aaral sa Ann Arbor
- Kanser sa Prostate27 pag-aaral
- Kanser sa Suso26 pag-aaral
- Kanser (lahat ng uri)26 pag-aaral
- Non-Small Cell Lung Cancer25 pag-aaral
- Colorectal Cancer23 pag-aaral
- Pagkabigo ng Puso22 pag-aaral
- Kanser sa Baga22 pag-aaral
- Acute Myeloid Leukemia17 pag-aaral
- Sakit sa Puso at Ugat ng Dugo16 pag-aaral
- Kanser sa Pancreas14 pag-aaral
- Melanoma12 pag-aaral
- Kanser sa Bato (Renal Cell Carcinoma)12 pag-aaral
Mula sa ClinicalTrials.gov, na-kuha noong Set 29, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.